Next-Generation Sequencing Identifies and Immunohistochemistry Confirms a Novel Crizotinib-Sensitive ALK Rearrangement in a Patient with Metastatic Non-Small-Cell Lung Cancer

被引:116
|
作者
Peled, Nir [1 ]
Palmer, Gary [2 ]
Hirsch, Fred R. [2 ]
Wynes, Murry W. [2 ]
Ilouze, Maya [1 ]
Varella-Garcia, Marileila [2 ]
Soussan-Gutman, Lior [4 ]
Otto, Geoff A. [3 ]
Stephens, Philip J. [3 ]
Ross, Jeffrey S. [3 ]
Cronin, Maureen T. [3 ]
Lipson, Doron [3 ]
Miller, Vincent A. [3 ]
机构
[1] Tel Aviv Univ, Chaim Sheba Med Ctr, Thorac Canc Res & Detect Ctr, IL-69978 Tel Aviv, Israel
[2] Univ Colorado, Ctr Canc, Dept Med, Div Med Oncol,UC Denver, Aurora, CO USA
[3] Fdn Med, Cambridge, MA USA
[4] Oncotest Teva Pharmaceut Ind, Petah Tiqwa, Israel
关键词
EML4-ALK FUSION GENE;
D O I
10.1097/JTO.0b013e3182614ab5
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
引用
收藏
页码:E14 / E16
页数:3
相关论文
共 50 条
  • [1] Next-Generation Sequencing Identified a Novel Crizotinib-Sensitive PLB1-ALK Rearrangement in Lung Large-Cell Neuroendocrine Carcinoma
    Wang, Shuai
    Wu, Xuan
    Zhao, Jiuzhou
    Chen, Haiyang
    Zhang, Zhe
    Wang, Mingyue
    Xu, Cong
    Wang, Yongsen
    Wang, Lili
    He, Zhen
    Wang, Qiming
    [J]. CLINICAL LUNG CANCER, 2021, 22 (03) : E366 - E370
  • [2] Effective Crizotinib Schedule for Brain Metastases in ALK Rearrangement Metastatic Non-Small-Cell Lung Cancer
    Peled, Nir
    Zach, Leor
    Liran, Ori
    Ilouze, Maya
    Bunn, Paul A., Jr.
    Hirsch, Fred R.
    [J]. JOURNAL OF THORACIC ONCOLOGY, 2013, 8 (12) : e112 - e113
  • [3] CUX1-ALK: A Novel ALK Rearrangement That Responds to Crizotinib in Non-Small-Cell Lung Cancer
    Zhang, M.
    Wang, Q.
    Ding, Y.
    Wang, G.
    Chu, Y.
    He, X.
    Wu, X.
    Shao, Y. W.
    Lu, K.
    [J]. JOURNAL OF THORACIC ONCOLOGY, 2018, 13 (10) : S800 - S800
  • [4] Crizotinib for ALK rearrangement in non small cell lung cancer
    Merrick, S. A.
    Hunter, S.
    Dalby, M.
    Neat, M.
    McMunagle, E.
    Montes, A.
    Lal, R.
    Ghosh, S.
    [J]. LUNG CANCER, 2017, 103 : S29 - S30
  • [5] Next-generation Sequencing Identified a Novel WDPCP-ALK Fusion Sensitive to Crizotinib in Lung Adenocarcinoma
    He, Zhen
    Wu, Xuan
    Ma, Shuxiang
    Zhang, Cuicui
    Zhang, Zhe
    Wang, Shuai
    Yu, Sheng
    Wang, Qiming
    [J]. CLINICAL LUNG CANCER, 2019, 20 (05) : E548 - E551
  • [6] The Utility of Next-Generation Sequencing in the Treatment Decision-Making for Metastatic Non-Small-Cell Lung Cancer
    Orlov-Slavu, Maria Cristina
    Popa, Ana Maria
    Tulin, Adrian
    Stoian, Anca Pantea
    Poiana, Catalina
    Paleru, Cristian
    Calu, Valentin
    Nitipir, Cornelia
    [J]. CUREUS JOURNAL OF MEDICAL SCIENCE, 2021, 13 (08)
  • [7] Advancements in next-generation sequencing for diagnosis and treatment of non-small-cell lung cancer
    Ying-Qiang Lu
    Kai-Hua Lu
    [J]. 慢性疾病与转化医学(英文), 2017, 3 (01) : 1 - 7
  • [8] Different histopathology but the same clonality: ALK rearrangement in a patient with metastatic non-small-cell lung cancer
    Zhao, Jing
    Zhou, Jianya
    Chen, Zhen
    Wang, Bo
    Zhang, Xiuming
    Zhou, Jianying
    Ding, Wei
    [J]. INTERNATIONAL JOURNAL OF CLINICAL AND EXPERIMENTAL PATHOLOGY, 2015, 8 (03): : 3344 - 3348
  • [9] Rapid Response of Brain Metastasis to Crizotinib in a Patient with ALK Rearrangement-Positive Non-Small-Cell Lung Cancer
    Kaneda, Hiroyasu
    Okamoto, Isamu
    Nakagawa, Kazuhiko
    [J]. JOURNAL OF THORACIC ONCOLOGY, 2013, 8 (04) : E32 - E33
  • [10] Next-generation Sequencing for ALK and ROS1 Rearrangement Detection in Patients With Non-small-cell Lung Cancer: Implications of FISH-positive Patterns
    Clave, Sergi
    Rodon, Natalia
    Pijuan, Lara
    Diaz, Olga
    Lorenzo, Marta
    Rocha, Pedro
    Taus, Alvaro
    Blanco, Remei
    Bosch-Barrera, Joaquim
    Reguart, Noemi
    de la Torre, Noelia
    Oliveras, Gloria
    Espinet, Blanca
    Bellosillo, Beatriz
    Puig, Xavier
    Arriola, Edurne
    Salido, Marta
    [J]. CLINICAL LUNG CANCER, 2019, 20 (04) : E421 - E429